Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bertolotto

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
European Cytokine Network|April 3, 2001
A Jurkat T cell variant resistant to death receptor-induced apoptosis. Correlation with heat shock protein (Hsp) 27 and 70 levelsJ E Ricci, L Maulon, V Battaglione-Hofman, et al.
Pigment Cell & Melanoma Research|April 23, 2008
Involvement of FKHRL1 in melanoma cell survival and deathC Hilmi, L Larribere, M Deckert, et al.
Molecular Biology of the Cell|June 17, 1998
Inhibition of Rho is required for cAMP-induced melanoma cell differentiationR Buscà, C Bertolotto, P Abbe, et al.
Oncogene|May 22, 2001
Differential requirements for ERK1/2 and P38 MAPK activation by thrombin in T cells. Role of P59Fyn and PKCepsilonL Maulon, B Mari, C Bertolotto, et al.
Oncogene|April 2, 1999
Tumor necrosis factor alpha-mediated inhibition of melanogenesis is dependent on nuclear factor kappa B activationW Englaro, P Bahadoran, C Bertolotto, et al.
Oncogene|February 1, 2011
Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progenyY Cheli, S Giuliano, S Guiliano, et al.
Oncogene|January 25, 2011
Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanomaT Strub, S Giuliano, T Ye, et al.
Oncogene|October 15, 2011
Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cellsY Cheli, S Giuliano, N Fenouille, et al.
The Journal of Biological Chemistry|July 25, 1998
Involvement of microphthalmia in the inhibition of melanocyte lineage differentiation and of melanogenesis by agouti signal proteinE Aberdam, C Bertolotto, E V Sviderskaya, et al.
Cell Death and Differentiation|July 3, 2010
Ciglitazone negatively regulates CXCL1 signaling through MITF to suppress melanoma growthT Botton, A Puissant, Y Cheli, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
European Cytokine Network|April 3, 2001
A Jurkat T cell variant resistant to death receptor-induced apoptosis. Correlation with heat shock protein (Hsp) 27 and 70 levelsJ E Ricci, L Maulon, V Battaglione-Hofman, et al.
Pigment Cell & Melanoma Research|April 23, 2008
Involvement of FKHRL1 in melanoma cell survival and deathC Hilmi, L Larribere, M Deckert, et al.
Molecular Biology of the Cell|June 17, 1998
Inhibition of Rho is required for cAMP-induced melanoma cell differentiationR Buscà, C Bertolotto, P Abbe, et al.
Oncogene|May 22, 2001
Differential requirements for ERK1/2 and P38 MAPK activation by thrombin in T cells. Role of P59Fyn and PKCepsilonL Maulon, B Mari, C Bertolotto, et al.
Oncogene|April 2, 1999
Tumor necrosis factor alpha-mediated inhibition of melanogenesis is dependent on nuclear factor kappa B activationW Englaro, P Bahadoran, C Bertolotto, et al.
Oncogene|February 1, 2011
Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progenyY Cheli, S Giuliano, S Guiliano, et al.
Oncogene|January 25, 2011
Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanomaT Strub, S Giuliano, T Ye, et al.
Oncogene|October 15, 2011
Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cellsY Cheli, S Giuliano, N Fenouille, et al.
The Journal of Biological Chemistry|July 25, 1998
Involvement of microphthalmia in the inhibition of melanocyte lineage differentiation and of melanogenesis by agouti signal proteinE Aberdam, C Bertolotto, E V Sviderskaya, et al.
Cell Death and Differentiation|July 3, 2010
Ciglitazone negatively regulates CXCL1 signaling through MITF to suppress melanoma growthT Botton, A Puissant, Y Cheli, et al.
Pageof 5